Inhalation Sciences is a focused CRO on inhalation and intranasal drug development, offering preclinical research and development services to successfully develop orally inhaled and intra-nasal drug products. Developing respiratory therapies presents specific challenges that Inhalation Sciences has addressed with proprietary and unique approaches in vitro, ex vivo and in vivo to generate accurate and predictive data and to de-risk clinical trials.
Inhalation Sciences can also support efficacy studies with disease models, toxicology studies, GLP and on-GLP, drug-device combination development and CMC tests for IND submission as well as bioequivalence studies, transportation studies etc.